| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |